Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Travels to Dream Objections in Europe - 2Photos of amputees in Gaza, struggling to survive after losing limbs to Israeli airstrikes
- 3Step by step instructions to Analyze Senior Insurance Contracts Really.
- 4Haifa refinery said hit in latest Iranian missile barrage
- 5Bring tissues and skip the mascara: The movie that's making theater-goers sob uncontrollaby
- Audits of 6 Specialty Mixed drinks
- Apartment Turned Into Nightmare 'Ice Castle' After Tenant Shut Off Heat Causing Pipes to Burst: VIDEO
- 2 ways you can conserve the water used to make your food
- Instructions to Pick the Ideal SUV Size for Seniors
- Figure out How to Pick a SUV with Senior-Accommodating Tech Elements
- German Cabinet advances bill to cut greenhouse emissions from fuels
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- 'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
- Treason trial of South Sudan's suspended VP is further eroding peace deal, UN experts say
